UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder

Journal of neuroendocrinology, 2018-02, Vol.30 (2), p.n/a

2018

Volltextzugriff (PDF)

Effect of hysterectomy on pain in women with endometriosis: a population‐based registry study

BJOG : an international journal of obstetrics and gynaecology, 2020-12, Vol.127 (13), p.1628-1635

2020

Volltextzugriff (PDF)

There is no association between combined oral hormonal contraceptives and depression: a Swedish register‐based cohort study

BJOG : an international journal of obstetrics and gynaecology, 2022-05, Vol.129 (6), p.917-925

2022

Volltextzugriff (PDF)

Allopregnanolone and mood disorders

Progress in neurobiology, 2014-02, Vol.113, p.88-94

2014

Volltextzugriff (PDF)

Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle—A double-blind, placebo-controlled randomized trial

Psychoneuroendocrinology, 2017-02, Vol.76, p.135-143

2017

Volltextzugriff (PDF)

Allopregnanolone involvement in feeding regulation, overeating and obesity

Frontiers in neuroendocrinology, 2018-01, Vol.48, p.70-77

2018

Volltextzugriff (PDF)

Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use

The European journal of contraception & reproductive health care, 2018-01, Vol.23 (1), p.45-51

2018

Volltextzugriff (PDF)

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital ® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

Medical devices (Auckland, N.Z.), 2020, Vol.13, p.339-347

2020

Volltextzugriff (PDF)

Sexual function and combined oral contraceptives: a randomised, placebo-controlled trial

Endocrine Connections, 2018, Vol.7 (11), p.1208-1216

2018

Volltextzugriff (PDF)

Pregnancy-related maternal physiological adaptations and fetal chemical exposure

Molecular and cellular endocrinology, 2023-12, Vol.578, p.112064-112064, Article 112064

2023

Volltextzugriff (PDF)

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)—A randomized controlled trial

Psychoneuroendocrinology, 2017-06, Vol.80, p.46-55

2017

Volltextzugriff (PDF)

Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial

The American journal of psychiatry, 2021-03, Vol.178 (3), p.256-265

2021

Volltextzugriff (PDF)

Altered GABAA receptor function in women with endometriosis: a possible pain‐related mechanism

Acta obstetricia et gynecologica Scandinavica, 2023-10, Vol.102 (10), p.1316-1322

2023

Volltextzugriff (PDF)

A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder

Psychoneuroendocrinology, 2021-11, Vol.133, p.105426-105426, Article 105426

2021

Volltextzugriff (PDF)

Neonatal outcome following metformin‐treated gestational diabetes mellitus: A population‐based cohort study

Acta obstetricia et gynecologica Scandinavica, 2024-05, Vol.103 (5), p.992-1007

2024

Volltextzugriff (PDF)

Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case–control study in Sweden

European journal of epidemiology, 2024-03, Vol.39 (3), p.313-322

2024

Volltextzugriff (PDF)

Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial

The lancet. Diabetes & endocrinology, 2019-04, Vol.7 (4), p.256-266

2019

Volltextzugriff (PDF)

Ulipristal acetate shows promise for treatment of PMDD

Psychopharmacology update, 2021-04, Vol.32 (4), p.2

2021

Volltextzugriff (PDF)

Allopregnanolone and progesterone in estradiol treated severe postpartum affective disorder

PSYCHONEUROENDOCRINOLOGY, 2019-09, Vol.107, p.68-68

2019

Volltextzugriff (PDF)

Altered GABAA receptor function in women with endometriosis: a possible pain-related mechanism

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, Vol.102, p.70

2023

Volltextzugriff (PDF)

Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder

BMC women's health, 2022-02, Vol.22 (1), p.35-35, Article 35

2022

Volltextzugriff (PDF)

Implications of antenatal depression and anxiety for obstetric outcome

Obstetrics and gynecology (New York. 1953), 2004-09, Vol.104 (3), p.467-476

2004

Volltextzugriff (PDF)

Point prevalence of psychiatric disorders during the second trimester of pregnancy: A population-based study

American journal of obstetrics and gynecology, 2003-07, Vol.189 (1), p.148-154

2003

Volltextzugriff (PDF)

Negative mood changes during hormone replacement therapy: A comparison between two progestogens

American journal of obstetrics and gynecology, 2000-12, Vol.183 (6), p.1419-1426

2000

Volltextzugriff (PDF)

Increased neurosteroid sensitivity – An explanation to symptoms associated with chronic work related stress in women?

Psychoneuroendocrinology, 2013-07, Vol.38 (7), p.1078-1089

2013

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(74)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder

Effect of hysterectomy on pain in women with endometriosis: a population‐based registry study

There is no association between combined oral hormonal contraceptives and depression: a Swedish register‐based cohort study

Allopregnanolone and mood disorders

Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle—A double-blind, placebo-controlled randomized trial

Allopregnanolone involvement in feeding regulation, overeating and obesity

Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital ® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

Sexual function and combined oral contraceptives: a randomised, placebo-controlled trial

Pregnancy-related maternal physiological adaptations and fetal chemical exposure

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)—A randomized controlled trial

Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial

Altered GABAA receptor function in women with endometriosis: a possible pain‐related mechanism

A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder

Neonatal outcome following metformin‐treated gestational diabetes mellitus: A population‐based cohort study

Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case–control study in Sweden

Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial

Ulipristal acetate shows promise for treatment of PMDD

Allopregnanolone and progesterone in estradiol treated severe postpartum affective disorder

Altered GABAA receptor function in women with endometriosis: a possible pain-related mechanism

Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder

Implications of antenatal depression and anxiety for obstetric outcome

Point prevalence of psychiatric disorders during the second trimester of pregnancy: A population-based study

Negative mood changes during hormone replacement therapy: A comparison between two progestogens

Increased neurosteroid sensitivity – An explanation to symptoms associated with chronic work related stress in women?

Suchergebnisse filtern